Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: Effects of fluoxetine

Brain, Behavior, and Immunity

Volumn 16, Issue 4, 2002, Pages 333-350

  Edgar, Valeria Ayelli ^a   Cremaschi, Graciela A ^a   Sterin Borda, Leonor ^a   Genaro, Ana María ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

cAMP; cGMP; Chronic mild stress; Fluoxetine; Lymphocyte; Muscarinic cholinergic receptor; Proliferation; adrenergic receptor

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR; CARBACHOL; CYCLIC AMP; CYCLIC GMP; FLUOXETINE; ISOPRENALINE; MITOGENIC AGENT; MUSCARINIC RECEPTOR; PROPRANOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; FOOD DEPRIVATION; ILLUMINATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; T LYMPHOCYTE ACTIVATION; WATER DEPRIVATION;

EID: 0036430128     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.2001.0632     Document Type: Article

References (49)

1. Ader, R., Felten, D. L., & Cohen, N. (1990). Interactions between the brain and immune system. Ann. Rev. Pharmacol. Toxicol. 30, 561-602.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual for Mental Disorders, 4th Ed. Washington DC: American Psychiatric Association.
3. Ayelli Edgar, V., Sterin-Borda, L., Cremaschi, G., & Genaro, A. M. (1999). Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. Eur. J. Pharmacol. 372, 65-73.
4. Baerwald, C. G. O., Graefe, P., von Wichert, P. & Krause, A. (1992). Decreased density of β-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J. Rheumatol. 19, 204-210.
5. Baerwald, C. G. O., Wahle, M., Ulrichs, T., Jonas, D, von Bierbraver, A., von Wichert, P., Burmester, G. R., & Krause, A. (1999). Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis. Immunobiology 200, 71-91.
6. Baldessarini, R. J. (1996) Drugs and treatment of psychiatric disorders. In J. G. Hardman, L. E. Limbird, & A. Goodman-Gilman (Eds.), The Pharmacological Basis of Therapeutics, 9th Ed., pp. 459-490. New York: McGraw-Hill.
7. Brown, B. L., Albano, J. D., Ekins, R. P., & Gherzi, A. M. (1971). A simple and sensitive saturation method for the measurement of adenosine 3′5′-cyclic monophosphate. Biochem. J. 121, 561-562.
8. Bruce, J., Symington, F. W., McKearn, T. J., & Sprent, J. (1981). A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127, 2469-2501.
9. Cazaux, C. A., Sterin-Borda, L., Gorelik, G., & Cremaschi, G. A. (1995). Down-regulation of β-adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes. FEBS. Lett. 364, 120-124.
10. Cheeta, S., Ruigt, G., van Proosdij, J., & Willner, P. (1997) Changes in sleep architecture following chronic mild stress. Biol. Psychiatr. 41, 419-427.
11. Coffey, R. J., & Hadden, J. W. (1985). Neurotransmitters, hormones and cyclic nucleotides in lymphocyte regulation. Fed. Proc. 44, 112-117.
12. Cohen, S., & Herbert, T. B. (1996). Health psychology: Psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu. Rev. Psychol. 47, 113-142.
13. Costa, L. G., Kaylor, G., & Murphy, S. D. (1988). Muscarinic cholinergic binding sites on rat lymphocytes. Immunopharmacology 16, 139-149.
14. Drabhar, F. S., & McEwen, B. S. (1996). Moderate stress enhances, and chronic stress suppresses, cell-mediated immunity "in vivo." Abstracts Soc. Neurosci. 22, 1350-1354.
15. Drabhar, F. S., & McEwen, B. S. (1999). Changes in blood leukocyte distribution: Interactions between catecholamine and glucocorticoid hormones. Neuroimmunomodulation 6, 213-214. [Abstract]
16. Dimsdale, J., Mills, P., & Patterson, T. (1994). The effects of chronic stress on β-adrenergic receptors. Psychosom. Med. 56, 290-295.
17. Edgar, V. A., Genaro, A. M., Cremaschi, G., & Sterin-Borda, L. (1998). Fluoxetine action on murine T-lymphocyte proliferation. Cell Signal. 10, 721-726.
18. Felten, S. Y., Felten, D. L., Bellinger, D. L. & Olschowka, J. A. (1992). Noradrenergic and peptidic innervation of lymphoid organs. In J. E. Blalock (Ed.), Chemical Immunology: Neuroimmunoendocrinology, pp. 25-48. Basel: S. Karger.
19. Freire-Garabal, P. M., Nunez, M. J., Losada, C., Pereiro, D., Riveiro, M. P., Gonzalez-Petino, E., Mayan, J. M., & Rey-Mendez, M. (1997). Effects of fluoxetine on the immunosupressive response to stress in mice. Life Sci. 60, PL 403-413.
20. Genaro, A. M., & Borda, E. (1989). Alloimmunization-induced changes in β-adrenoceptor expression and cAMP on B lymphocytes. Immunopharmacology 18, 63-70.
21. Genaro, A. M., Cremaschi, G. A., & Borda, E. S. (1993). Muscarinic cholinergic receptors on murine lymphocyte subpopulations. Immunopharmacology 26, 21-29.
22. Herbert, T. B., & Cohen, S. (1993). Depression and immunity: A meta-analytic review. Psychol Bull. 113, 472-486.
23. Hosey, M. M. (1992). Diversity of structure, signaling, and regulation within the family of muscarinic cholinergic receptors. FASEB J. 6, 845-852.
24. Irwin, M. (1995). Psychoneuroimmunology of depression. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, pp. 983-988. New York: Raven Press.
25. Julius, M. H., Simpson, E., & Herzenberg, L. A. (1973). A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3, 645-652.
26. Kavelaars, A., Kuis, W., Knook, L., Sinnema, G. & Heijen, C. J. (1999). Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 85, 692-696.
27. Kiecolt-Glaser, J. K., Dura, J. R., Speicher, C. E., Trask, O. J., & Glaser, R. (1991). Spousal caregivers of dementia victims: Longitudinal changes in immunity and health. Psychosom. Med. 53, 345-362.
28. Kiecolt-Glaser, J. K., Glaser, R., Shuttleworth, E. C., Dyer, C. S., Ogroki, P. & Speicher, C. E. (1987). Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom. Med. 49, 523-535.
29. 2 receptors in the chronic mild stress model of depression in rats. Pol. J. Pharmacol. 46, 67-69.
30. Kubera, M., Skowron-Cendrzak, A., & Mazur-Kolecka, B. (1992). Stress-induced changes in muscarinic and beta-adrenergic binding sites on rat thymocytes and lymphocytes. J. Neuroimmunol. 37, 229-235.
31. Li, Y. S., Kovassi, E., & Revillard, J. P. (1990). Differential regulation of mouse B-cell activation by β-adrenoceptor stimulation depending on type of mitogen. Immunology 69, 367-372.
32. Lombardi, M. S., Kavellars, A., Schedlowsky, M., Bijlsma, J. W., Okihara, K. L., Van de Pol, M., Ochsmann, S., Pawlak, C., Schmidt, R. E. & Heijen, C. J. (1999). Descreased expression and activity of G protein-coupled receptor kinases by peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 13, 715-725.
33. Maes, M. (1995). Evidence for an immune response in major depression: A review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiat. 19, 11-38.
34. Malinski, W., Kullberg, M., Nordstrom, O., & Bartfai, T. (1988). Muscarinic receptors and receptor-mediated actions in rat thymocytes. J. Neuroimmunol. 17, 265-274.
35. 2-adrenergic receptor alterations in elderly Alzheimer caregivers under stress. Psychosom Med. 59, 251-256.
36. Monleon, S., D'Aquila, P., Parra, A., Simon, V. M., Brain, P. F., & Willner, P. (1995). Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117, 453-457.
37. Munson, P. J., & Rodbard, D. (1980). Ligand, a versatile computarized approach for characterization of ligand-binding systems. Ann. Biochem. 107, 220-239.
38. Muscat, R., Papp, M., & Willner, P. (1992). Reversal of stress-induced anhedonia by the atypical antidepressants fluoxetine and maprotiline. Psychopharmacology 109, 433-438.
39. Neliboff, B. D., Benton, D., Solomon, G. F., Morley, J. E., Fahey, J. L.; Bloom, E. T., & Makinodan, T. (1991). Immunological changes in young and old adults during brief laboratory stress. Psychosom. Med. 53, 121-131.
40. Overstreet, D. H., & Steiner, M. (1998). Genetic and environmental models of stress-induced depression in rats. Stress Med. 14, 261-268.
41. Ravindran, A. V., Griffiths, J., Merali, Z., & Anisman, H. (1998) Circulating lymphocyte subsets in major depression and dysthimia with typical or atypical features. Psychosom. Med. 60, 283-289.
42. Sanders, V. M., & Munson, A. F. (1984). Beta-adrenoceptor mediator of enhancing effect of norepinephrine on the murine primary antibody response in vitro. J Pharmacol Exp. Ther. 230, 183-192.
43. Tamir, A., Granot, Y., & Isakov, N. (1996). Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two paralell mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-JUN N-terminal kinase. J. Immunol. 157, 1514-1522.
44. Weinstein, Y., Segal, S., & Melmor, K. L. (1975). Specific mitogenic activity of 8-Br-guanosine 3′5′-monophosphate (Br-cyclic GMP) on B lymphocytes. J. Immunol. 115, 112-117.
45. Werner, C., Poller, V., & Brodde, O. (1997). Chronic terbutaline treatment desensitizes beta-adrenergic inhibition of lymphocyte activation in healthy volunteers. J. Auton. Pharmacol. 17, 237-242.
46. Willner, P. (1997). Validity, reliabillity and utility of the chronic mild stress model of depression. Psychopharmacology 134, 319-329.
47. Willner, P., Muscat, R., & Papp, M. (1992). Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci. Biobehav. Rev. 16, 525-534.
48. Yamamura, H. I., & Snyder, S. H. (1974). Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA 71, 1725-1729.
49. Yloman, J. S. (1995). Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 12, 3-16.